Term Name: | afamelanotide |
---|---|
Synonyms: | 4-Nle-7-Phe-alpha-MSH, [Nle(4),D-Phe(7)]-alpha-MSH, Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2, afamelanotida, afamelanotide, afamelanotidum, CUV 1647, CUV-1647, CUV1647, melanotan I, melanotan-1, N-acetyl-L-seryl-L-tyrosyl-L-seryl-L-norleucyl-L-alpha-glutamyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophylglycyl-L-lysyl-L-prolyl-L-valinamide, N-acteyl-L-Ser-L-Tyr-L-Ser-L-Nle-L-Glu-L-His-D-Phe-L-Arg-L-Trp-Gly-L-Lys-L-Pro-L-Val-NH2, NDP-alpha-MSH, NDP-MSH, Nle(4)-D-Phe(7)-alpha-melanocyte-stimulating hormone, Scenesse |
Definition: | A polypeptide comprising of 13 amino acids which is an analogue of alpha-melanocyte stimulating hormone. It is approved as a dermatologic drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. |
Ontology: | ChEBI [CHEBI:136034] ( EBI ) |